⌘K

Home/Filings/4/0001654954-20-004552

4//SEC Filing

Schafer Edward T 4

Accession 0001654954-20-004552

CIK 0001378624other

View on SEC.gov Company Profile

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 4:24 PM ET

Size

5.0 KB

Accession

0001654954-20-004552

Insider Transaction Report

Form 4

Period: 2020-04-25

Cellular Biomedicine Group, Inc.CBMG

Schafer Edward T

Director

Transactions

Award
Non-qualified stock option (right to buy)
2020-04-25+4,983→ 4,983 total
Exercise: $14.65From: 2021-04-23Exp: 2023-04-25→ Common Stock (4,983 underlying)

Footnotes (1)

[F1]This option becomes exercisable and fully vests on April 23, 2021.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Cellular Biomedicine Group, Inc.

CIK 0001378624

Entity typeother

Related Parties

1

filerCIK 0001376093

Filing Metadata

Form type: 4
Filed: Apr 27, 8:00 PM ET
Accepted: Apr 28, 4:24 PM ET
Size: 5.0 KB

View on SEC.gov